Free Trial

Nuvectis Pharma (NVCT) SEC Filings & 10K Form

Nuvectis Pharma logo
$9.83 -0.12 (-1.21%)
Closing price 04:00 PM Eastern
Extended Trading
$9.85 +0.02 (+0.15%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Nuvectis Pharma SEC Filings

DateFilerForm TypeView
05/13/2025
5:36 PM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
8:25 AM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4/A
05/09/2025
5:53 PM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:12 PM
Nuvectis Pharma (Filer)
Form 424B5
05/09/2025
4:20 PM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
7:36 AM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
8:26 AM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
4:58 PM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
5:30 AM
Nuvectis Pharma (Filer)
Form 424B5
02/05/2025
8:51 PM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
5:09 PM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
5:10 PM
Carson Michael J. (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
5:12 PM
Nuvectis Pharma (Issuer)
Poradosu Enrique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
5:13 PM
Nuvectis Pharma (Issuer)
Shemesh Shay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
7:00 AM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
4:37 PM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4/A
12/16/2024
7:00 AM
Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
7:30 AM
Nuvectis Pharma (Issuer)
Poradosu Enrique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
7:30 AM
BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
2:59 PM
Carson Michael J. (Reporting)
Nuvectis Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
9:55 AM
Nuvectis Pharma (Subject)
Pontifax Management 4 G.P. Ltd. (0001726334) (Filed by)
Form SC 13G/A
11/05/2024
7:31 AM
Nuvectis Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
6:08 AM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2024
7:52 AM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
3:09 PM
Nuvectis Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NVCT) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners